Clinical Trial Update: SmartWatch ECG Evaluation Trial I [NA]

View source ↗

Summary

A clinical trial evaluating a smartwatch ECG for atrial fibrillation has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atrial Fibrillation

Snippet

Sponsor: University of Oklahoma | Conditions: Atrial Fibrillation | NA | Status: WITHDRAWN